Cover: Drug Prices and Emergency Department Mentions for Cocaine and Heroin

Drug Prices and Emergency Department Mentions for Cocaine and Heroin

Published 2001

by Jonathan P. Caulkins

Purchase Print Copy

 Format
Add to Cart Paperback3 pages Free

The author correlated price series based on the Drug Enforcement Administration's System to Retrieve Information from Drug Evidence database with data on emergency department mentions from the Drug Abuse Warning Network for cocaine (1978-1996) and heroin (1981-1996). A simple model in which emergency department mentions are driven only by prices explains more than 95% of the variations in emergency department mentions. The author concludes that fluctuations in prices are an important determinant of adverse health outcomes associated with drugs.

Originally published in: American Journal of Public Health, v. 91, no. 9, September 2001, pp. 1446-1448.

This report is part of the RAND reprint series. The Reprint was a product of RAND from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.